Thomas A Treibel1, Charlotte Manisty1, Mervyn Andiapen2, Corinna Pade3, Melanie Jensen4, Marianna Fontana5, Xosé Couto-Parada6, Teresa Cutino-Moguel6, Mahdad Noursadeghi7, James C Moon8. 1. Institute of Cardiovascular Science, University College London, London, UK; Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK. 2. Centre for Cardiovascular Medicine and Devices, Queen Mary University of London, London, UK. 3. William Harvey Research Institute, Queen Mary University of London, London, UK; The Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. 4. Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK. 5. National Amyloidosis Centre, Division of Medicine, University College London, London, UK; Royal Free London NHS Foundation Trust, London, UK. 6. Department of Virology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK. 7. Division of Infection and Immunity, University College London, London, UK. 8. Institute of Cardiovascular Science, University College London, London, UK; Department of Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK. Electronic address: j.moon@ucl.ac.uk.
Kevin Fennelly and Christopher Whalen emphasise that health-care workers (HCWs) are at a higher risk of severe acute respiratory syndrome coronavirus 2 infection than are the general population. Angela Chow and colleagues describe their experience in Singapore of very low rates of HCW infections and nosocomial transmission when effective personal protective equipment is implemented. We agree with both perspectives, and our Correspondence did not contradict either of these viewpoints.Front-line HCWs have a reported hazard ratio of more than 3 compared with the general community. This risk is variable between studies, with reported seropositivity rates in the UK ranging from 6% to 43% across different hospital settings.3, 4 Explanations for this variation include confounding by sampling timepoints during an emerging epidemic wave, participant selection (random vs symptomatic), and rates of self-isolation, and differences in the nature of exposures, policies for infection control, and use of personal protective equipment.Our study was done when symptomatic HCWs were already required to quarantine. We sought to address the need for repeated mass screening of staff without disease-defining symptoms to help to reduce transmission associated with health care. Therefore, we focused on asymptomatic or pauci-symptomatic infection in HCWs at sequential timepoints during the first epidemic wave in London, UK, sampling only HCWs who attended work because they did not meet the symptomatic criteria to self-isolate. PCR-positive results peaked one week before the PCR-positive peak in London (which was at that time reflected mainly by symptomatic patients presenting to hospitals). We inferred from this that the peak of asymptomatic infection in our HCW cohort coincided with the peak of virus circulation in the community. Thereafter, the rates of prevalent asymptomatic infection in our cohort reduced in line with the decline in community cases, despite a persistent number of patients with COVID-19 within the hospital. Further serial swabbing of HCWs over 16 weeks to mid-August, 2020, showed no new cases (appendix p 1) and neither did extension to two further hospitals and a total of 731 participants who were studied longitudinally (data not shown). The number of HCWs who were self-isolating fell to nearly zero over this time period. Despite some persistent hospitalised cases, zero cases were identified by PCR and nearly zero HCWs were self-quarantining by approximately 4 weeks after the peak, suggesting that nosocomial transmission had ceased. A key contributor to the absence of ongoing nosocomial transmission was likely to be the effective implementation of infection control practices.Our approach to focus on asymptomatic infections underestimates the absolute incident rate of infections among HCWs, but it identifies the scale of infection missed by case-definition criteria and is likely to be a fair surrogate for the trend of incident infections. These data suggest that tracking community prevalence to trigger asymptomatic screening of HCWs is more informative than monitoring hospital caseloads.
Authors: Thomas A Treibel; Charlotte Manisty; Maudrian Burton; Áine McKnight; Jonathan Lambourne; João B Augusto; Xosé Couto-Parada; Teresa Cutino-Moguel; Mahdad Noursadeghi; James C Moon Journal: Lancet Date: 2020-05-08 Impact factor: 79.321
Authors: Catherine F Houlihan; Nina Vora; Thomas Byrne; Dan Lewer; Gavin Kelly; Judith Heaney; Sonia Gandhi; Moira J Spyer; Rupert Beale; Peter Cherepanov; David Moore; Richard Gilson; Steve Gamblin; George Kassiotis; Laura E McCoy; Charles Swanton; Andrew Hayward; Eleni Nastouli Journal: Lancet Date: 2020-07-09 Impact factor: 79.321
Authors: Long H Nguyen; David A Drew; Mark S Graham; Amit D Joshi; Chuan-Guo Guo; Wenjie Ma; Raaj S Mehta; Erica T Warner; Daniel R Sikavi; Chun-Han Lo; Sohee Kwon; Mingyang Song; Lorelei A Mucci; Meir J Stampfer; Walter C Willett; A Heather Eliassen; Jaime E Hart; Jorge E Chavarro; Janet W Rich-Edwards; Richard Davies; Joan Capdevila; Karla A Lee; Mary Ni Lochlainn; Thomas Varsavsky; Carole H Sudre; M Jorge Cardoso; Jonathan Wolf; Tim D Spector; Sebastien Ourselin; Claire J Steves; Andrew T Chan Journal: Lancet Public Health Date: 2020-07-31
Authors: Aneesh Chandran; Joshua Rosenheim; Gayathri Nageswaran; Leo Swadling; Gabriele Pollara; Rishi K Gupta; Alice R Burton; José Afonso Guerra-Assunção; Annemarie Woolston; Tahel Ronel; Corinna Pade; Joseph M Gibbons; Blanca Sanz-Magallon Duque De Estrada; Marc Robert de Massy; Matthew Whelan; Amanda Semper; Tim Brooks; Daniel M Altmann; Rosemary J Boyton; Áine McKnight; Gabriella Captur; Charlotte Manisty; Thomas Alexander Treibel; James C Moon; Gillian S Tomlinson; Mala K Maini; Benjamin M Chain; Mahdad Noursadeghi Journal: Cell Rep Med Date: 2022-03-04
Authors: Gabriella Captur; James C Moon; Constantin-Cristian Topriceanu; George Joy; Leo Swadling; Jenny Hallqvist; Ivan Doykov; Nina Patel; Justyna Spiewak; Tomas Baldwin; Matt Hamblin; Katia Menacho; Marianna Fontana; Thomas A Treibel; Charlotte Manisty; Ben O'Brien; Joseph M Gibbons; Corrina Pade; Tim Brooks; Daniel M Altmann; Rosemary J Boyton; Áine McKnight; Mala K Maini; Mahdad Noursadeghi; Kevin Mills; Wendy E Heywood Journal: EBioMedicine Date: 2022-09-27 Impact factor: 11.205